Gaslightwala Abizerinsider trades
In SEC Form 4 filings, Gaslightwala Abizer is listed as CEO of Akari Therapeutics Plc (AKTX). Gaslightwala Abizer reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AKTXAkari Therapeutics Plc | CEO | 6 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 19,333 | $0.00 | $8 | 33,440 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 7,733 | $0.00 | $3 | 41,173 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 19,333 | $16.16 | $312,421 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 7,733 | $16.16 | $124,965 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 174,000 | $7.90 | $1,374,426 | 174,000 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Sep 29 | Oct 1 | A | 6,430 | $9.72 | $62,500 | 14,107 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.